Posts Tagged ‘biotech’

« Older Entries
Newer Entries »

M&A activity for small and mid-cap biotechs could pick up in 2010, JP Morgan analyst says

Wednesday, June 2nd, 2010

Earlier this year, J.P. Morgan’s senior biotech analyst, Geoff Meacham gave his macro view of the biotech industry. “M&A activity for small and mid-cap biotech may pick up, driven by Pharma but also driven by large cap biotechs,” he said. “In this report, we’ve stressed pipelines and sustainability of growth, but as growth in the large cap group matures, increased cash flow generation may fuel increased M&A activity.”

A few notable names with “high strategic values” included: Acorda Therapeutics, Inc. (Nasdaq: ACOR), AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG), OSI Pharmaceuticals, Inc. (Nasdaq: OSIP), Medivation, Inc. (Nasdaq: MDVN), United Therapeutics Corp. (Nasdaq: UTHR), Vertex Pharmaceuticals, Inc. (Nasdaq: VRTX), Human Genome Sciences, Inc. (Nasdaq: HGSI), Seattle Genetics, Inc. (Nasdaq: SGEN) and Savient Pharmaceuticals, Inc. (Nasdaq: SVNT).”

Lehman bullish on small, mid-caps, too:

“Opportunities for the U.S. biotechnology group are selective and we tend to prefer small-mid cap stocks over large-cap stocks overall in 1H10,” said Lehman Brothers analyst, Jim Birchenough. “Within the large cap group our rank order of preference is Amgen, Genzyme and Celgene as top picks with Gilead and Biogen Idec viewed less favorably. Top mid-cap picks include Amylin Pharmaceuticals (Nasdaq: AMLN), Cephalon (Nasdaq: CEPH), Human Genome Sciences (Nasdaq: HGSI), Onyx Pharmaceuticals (Nasdaq: ONXX) and Regeneron Pharmaceuticals(Nasdaq: REGN) while we are less positive on Theravance (Nasdaq: THRX), OSI Pharmaceuticals (Nasdaq: OSIP) and Zymogenetics(Nasdaq: ZGEN).

Biotech Buzz Stocks for 2010:

Here are a few of our favorite small and mid cap biotech Buzz Stocks for 2010:  Akorn, Inc. (Nasdaq: AKRX), Neurocrine Biosciences, Inc. (Nasdaq: NBIX), Metabolix, Inc. (Nasdaq: MBLX), and Raptor Pharmaceuticals Corp.

Let us know your top biotech picks!

Tags: , , , , , , , , , , , , , , , , ,
Posted in Health Care Stocks, Penny Stocks | No Comments »

Penny Buzz Stocks to Watch – ENMD, IMUC, OOAG

Wednesday, June 2nd, 2010

Here are a few penny stocks on our radar today and why:

Entremed, Inc. (Nasdaq: ENMD): announced the publication of preclinical results for its clinical-stage Aurora A/angiogenic kinase inhibitor, ENMD-2076, in human colorectal cancer xenograft models. ENMD-2076 demonstrated robust antitumor activity against murine xenograft models of human colorectal cancer (CRC) established from both cell lines and primary human samples.

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC): Announced positive results from a Phase I study of the company’s immune-based cancer therapy, ICT-107.

OMDA Oil and Gas, Inc. (Pink Sheets: OOAG): Announced a reduction of 12,000,000 common shares which is 5 percent of the total outstanding share count. Upon the completion of all of the announced share retirements the new outstanding share count will stand at 172,610,100. In total OMDA Oil and Gas, Inc. will have reduced its outstanding share total nearly 30% from the original 242,610,100. Upon completion of all pending share cancellations OMDA’s insiders will collectively hold less than 10% of the common vote.

Sign up for our Buzz Stock alerts via e-mail and get our Buzz Stocks first!

Tags: , , ,
Posted in Health Care Stocks, Materials Stocks, Penny Stocks | No Comments »

Vasomedical, Inc. (VASO) – Penny Stock of the Day

Monday, May 24th, 2010

Shares of Vasomedical, Inc. (OTCBB: VASO) were up as much as 86 percent on Monday after the company announced that its subsidiary was appointed the exclusive representative for select GE Healthcare Diagnostic Imaging products to specific market segments in the 48 contiguous states of the United States and District of Columbia received signed a sales representative agreement. GE Healthcare is the healthcare business unit of GE (NYSE: GE – News). The Company has already received financial commitments for up to $5 million to fund this project.

[–quote–]

“This representation agreement is an example of Vasomedical’s strategy to expand its operations into new areas of potential growth in healthcare,” stated Abraham E. Cohen, Chairman of the Board of Vasomedical, Inc. in a statement.

The agreement is for an initial term of three years commencing July 1, 2010, subject to extension and also subject to earlier termination under certain circumstances.

Vasomedical, Inc. is primarily engaged in designing, manufacturing, marketing and supporting EECP(R) external counterpulsation systems based on the Company’s proprietary technology. Offered exclusively by Vasomedical, EECP therapy is a safe, non-invasive, outpatient treatment option for patients suffering from ischemic heart diseases such as angina and heart failure

In early April, the company announced that it received clearance from the U.S. Food and Drug Administration to market its Vasomedical-BIOX™ Model 2301 Combined ECG Holter and Ambulatory Blood Pressure Monitoring Recorder and Software Analysis System.

“These are the first in a line of Vasomedical-BIOX™ ECG Holter and Ambulatory Blood Pressure Monitoring Systems that Vasomedical intends to bring to the marketplace,” said Dr. Jun Ma, President and CEO of Vasomedical, Inc.

Shares of Vasomedical are up more than 300 percent over the past 12 months.

Tags: , , , , , ,
Posted in Health Care Stocks, Penny Stocks, Technology Stocks | No Comments »

Metabolix, Inc. (MBLX) – Buzz Stock of the Day

Wednesday, May 12th, 2010

Shares of bioplastics developer, Metabolix, Inc. (Nasdaq: MBLX) surged as much as 18 percent in morning trading on Wednesday after the company announced the U.S. Food and Drug Administration approved its plastics products Mirel F1005 and F1006 for use in food contact applications.

[–quote–]

“With the Clinton plant now in operation, and this FDA clearance, we now can move forward with brand owners’ requests to use Mirel in their injection molded food packaging applications,” said Richard Eno, CEO of Metabolix in a statement. “These applications, which currently consume billions of pounds of petroleum-based polymers per year, offer considerable opportunity for growth of our biobased, biodegradable polymer, Mirel.”

Metabolix shares are up 54 percent over the past three months

Tags: , , ,
Posted in Health Care Stocks | 1 Comment »

Synergetics USA (SURG) – Buzz Stock of the Day

Wednesday, April 28th, 2010

Shares of medical device maker Synergetics USA, Inc. (Nasdaq: SURG) were up as much as 72 percent today after the company said Alcon Laboratories Inc (ACL.N) agreed to pay $32 million for the right to sell some of Synergetics’ products worldwide and to settle all pending litigation between the two companies.


Earlier this month, Synergetics announced a strategic agreement with Stryker Corporation. The agreement includes the sale of Synergetics’ accounts receivable, open sales orders, inventory and certain intellectual property related to the Omni® product line. In addition, the agreement provides for Synergetics to supply disposable ultrasonic instrument tips and certain other consumable products used in conjunction with the Sonopet/Omni® ultrasonic aspirator console and handpieces; and pursue certain development projects for new products associated with Stryker’s intraoperative ultrasound products.

Synergetics will receive between $2.5 million and $3.0 million in proceeds from the transactions once all inventory transfers are completed.

For the quarter ended Jan. 31, Synergetics profit more than doubled to $877,000, or 4 cents per share, from $389,000, or 2 cents per share, in the same period a year earlier. Second quarter revenue slipped to $13 million from $13.7 million due to lower sales neurosurgical products

The company reduced its sales and marketing costs by about $900,000, and trimmed its general and administrative and research and development spending.

Shares of Synergetics have been up as much as 139 percent over the past three months.



Tags: , , ,
Posted in Health Care Stocks | No Comments »

« Older Entries
Newer Entries »